Global Health

1,235.55
+29.15
(2.42%)
Market Cap
32,402.40 Cr
EPS
12.58
PE Ratio
65.36
Dividend Yield
0.00 %
52 Week High
1,511.00
52 Week low
935.50
PB Ratio
10.56
Debt to Equity
0.55
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy63.64 %
63.64 %
Hold18.18 %
18.18 %
Sell18.18 %
18.18 %

Company News

View All News
Caret
positive
NCLT Approves Merger of Medanta Holdings with Global Health1 day ago
The National Company Law Tribunal (NCLT) has approved the scheme of amalgamation between Medanta Holdings and Global Health. This merger represents a significant corporate action in the healthcare sector, potentially consolidating operations and resources of the two entities.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,010.25 1,00,309.40 92.57 5,584.10 18.77 1,058 -17.46 41.32
6,317.55 91,892.10 69.35 19,165.50 14.74 917 49.14 33.93
619.35 46,044.90 59.21 6,931.20 8.99 645 89.49 46.36
1,235.55 32,402.40 65.36 2,759.20 25.09 326 15.71 68.44
1,396.80 28,703.50 36.48 5,093.40 10.96 790 2.66 58.76
535.45 21,687.50 61.53 2,511.20 12.94 336 20.76 28.70
414.95 20,844.70 79.01 3,723.70 22.85 205 -69.22 29.16
1,322.95 13,197.10 56.31 1,334.00 10.76 218 10.06 40.97
1,490.40 9,768.40 50.73 1,095.50 21.32 177 20.14 42.36
499.75 7,074.70 125.63 1,929.10 12.97 41 129.41 48.64
Growth Rate
Revenue Growth
25.09 %
Net Income Growth
66.21 %
Cash Flow Change
107.07 %
ROE
10.63 %
ROCE
12.64 %
EBITDA Margin (Avg.)
10.54 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
Total Assets
1,984
2,430
2,666
2,694
3,146
4,116
Fixed Assets
1,094
1,194
1,703
1,616
1,776
2,050
Current Assets
472
489
479
502
812
1,580
Capital Work in Progress
317
666
382
464
439
327
Investments
0
0
0
0
0
0
Other Assets
573
570
582
615
930
1,739
Total Liabilities
1,984
2,430
2,666
2,694
3,146
4,116
Current Liabilities
334
296
358
405
420
573
Non Current Liabilities
432
839
959
907
1,110
1,115
Total Equity
1,217
1,296
1,350
1,382
1,616
2,428
Reserve & Surplus
1,136
1,214
1,268
1,300
1,565
2,375
Share Capital
81
49
49
50
51
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
Net Cash Flow
-0
-20
3
14
87
-78
50
648
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
Operating Activities
213
228
63
166
175
242
311
645
Financing Activities
-88
-7
9
97
-1
-81
160
346

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 hours ago
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
7 hours ago
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 10, 2025, 13:22
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 06, 2025, 16:06
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 06, 2025, 16:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 06, 2025, 15:55
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 05, 2025, 18:23
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 05, 2025, 13:01
Announcement under Regulation 30 (LODR)-Credit Rating
Feb 05, 2025, 12:54
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 04, 2025, 18:43
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 04, 2025, 18:28
Integrated Filing (Financial)
Feb 04, 2025, 18:10
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 04, 2025, 17:30
Announcement under Regulation 30 (LODR)-Meeting Updates
Feb 04, 2025, 16:42
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 For Unaudited Standalone And Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 3
Feb 04, 2025, 16:30
Unaudited Standalone And Consolidated Financial Results For Third Quarter And Nine Months Ended December 31 2024
Feb 04, 2025, 16:20
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 24, 2025, 11:07
Announcement under Regulation 30 (LODR)-Credit Rating
Jan 21, 2025, 17:15
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31 2024.
Jan 21, 2025, 15:59
Announcement under Regulation 30 (LODR)-Change in Management
Jan 14, 2025, 18:46
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Jan 13, 2025, 17:47
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Order Reserved By The Honble National Company Law Tribunal New Delhi Bench
Jan 08, 2025, 18:17
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 07, 2025, 12:36
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Dec 28, 2024, 17:39
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Dec 28, 2024, 17:37
Closure of Trading Window
Dec 27, 2024, 12:57

Technical Indicators

RSI(14)
Neutral
65.61
ATR(14)
Less Volatile
48.56
STOCH(9,6)
Neutral
69.43
STOCH RSI(14)
Overbought
83.43
MACD(12,26)
Bullish
9.99
ADX(14)
Strong Trend
25.04
UO(9)
Bearish
65.69
ROC(12)
Uptrend But Slowing Down
4.64
WillR(14)
Overbought
-16.35